野生動物医療市場- 世界の産業規模、シェア、動向、機会、予測、動物タイプ別、製品別、投与経路別、最終用途別、地域別、競合別、2019年～2029年

世界の野生動物医療市場は2023年に24億5,000万米ドルと評価され、2029年までのCAGRは8.75%で、予測期間中に力強い成長が予測されています。

世界の野生動物医療市場は、野生動物保護、公衆衛生、獣医学が交差する急成長分野です。人間の健康、動物の健康、環境保全の間の複雑なつながりに対する認識が高まるにつれ、市場は近年著しい成長を遂げています。この市場拡大の主な原動力のひとつは、エボラ出血熱やSARS、とりわけCOVID-19の大流行によって証明されたように、動物から人へ感染する人獣共通感染症がもたらす脅威の認識です。その結果、野生動物個体群の疾病を監視、診断、管理することを目的とした野生動物衛生製品やサービスに対する需要が急増しています。これには、リモートセンシング装置や分子診断などの疾病監視技術や、野生動物種に合わせた革新的なワクチンや治療薬が含まれます。

人間、動物、環境の健康が相互に関連していることを強調する、総合的なワンヘルスアプローチへのパラダイムシフトが起きています。このアプローチは、疾病の予防と制御の重要な要素として、生物多様性と生態系の保全の重要性を強調しています。その結果、世界の野生動物医療市場には生物医学的介入だけでなく、生息地の回復、野生動物の保護、野生動物の取引規制などの生態系管理戦略も含まれます。

この市場の特徴は、政府機関、非営利団体、研究機関、製薬会社、野生動物保護団体など、多様な利害関係者が存在することであり、これらすべてが政策の形成、調査への資金提供、介入策の実施において重要な役割を果たしています。しかし、この市場は資金調達の制約、規制のハードル、多様な野生生物種や生態系を扱う特有の複雑さなどの課題にも直面しています。さらに、動物福祉や先住民の権利など、野生生物の調査と管理をめぐる倫理的配慮は、慎重な審議を必要とする重要な問題を提起しています。

市場促進要因

人獣共通感染症の脅威の増加

技術の進歩

ワンヘルスアプローチの拡大

主な市場課題

資金調達の制約

規制上のハードル

データの制限

主な市場動向

人獣共通感染症の脅威に対する意識の高まり

官民投資の増加

セグメント別洞察

動物タイプ別洞察

製品別洞察

地域別洞察

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の野生動物医療市場の展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 動物タイプ別（哺乳類、鳥類、魚類、爬虫類、両生類）
  • 製品別（医薬品、機器・消耗品）
  • 投与経路別（経口剤、注射剤、その他）
  • エンドユーザー別（動物園、野生動物保護区、野生動物レスキュー＆リハビリセンター、その他）
  • 地域別
  • 企業別（2023年）
• 市場マップ
  • 動物タイプ別
  • 製品別
  • 投与経路別
  • 最終用途別
  • 地域別

第6章 アジア太平洋の野生動物医療市場の展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 動物タイプ別
  • 製品別
  • 投与経路別
  • 用途別
  • 国別
• アジア太平洋地域国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第7章 欧州の野生動物医療市場の展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 動物タイプ別
  • 製品別
  • 投与経路別
  • 用途別
  • 国別
• 欧州国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第8章 北米の野生動物医療市場の展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 動物タイプ別
  • 製品別
  • 投与経路別
  • 用途別
  • 国別
• 北米国別分析
  • 米国
  • メキシコ
  • カナダ

第9章 南米の野生動物医療市場の展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 動物タイプ別
  • 製品別
  • 投与経路別
  • 用途別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの野生動物医療市場の展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • 動物タイプ別
  • 製品別
  • 投与経路別
  • 用途別
  • 国別
• MEA：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • エジプト

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 製品発表（ある場合）
• M&A（もしあれば）

第13章 世界の野生動物医療市場SWOT分析

第14章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第15章 競合情勢

• Boehringer Ingelheim International GmbH
• NexGen Pharmaceuticals LLC
• Virbac S.A.
• Dong Bang Co., Ltd.
• Pneu-Dart Inc.
• DANiNJECT
• Genia Inc.
• Wedgewood Pharmacy LLC
• The Pet Apothecary
• Taylors Pharmacy LLC

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Wildlife Health Market was valued at USD 2.45 Billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 8.75% through 2029. The Global Wildlife Health Market represents a burgeoning sector at the intersection of wildlife conservation, public health, and veterinary science. With increasing awareness of the intricate connections between human health, animal health, and environmental integrity, the market has seen significant growth in recent years. One of the primary drivers of this expansion is the recognition of the threats posed by zoonotic diseases, which can jump from animals to humans, as evidenced by outbreaks such as Ebola, SARS, and most notably, the COVID-19 pandemic. Consequently, there's been a surge in demand for wildlife health products and services aimed at monitoring, diagnosing, and managing diseases in wild animal populations. This includes technologies for disease surveillance, such as remote sensing devices and molecular diagnostics, as well as innovative vaccines and therapeutics tailored to wildlife species.

There's been a paradigm shift towards a holistic One Health approach, which emphasizes the interconnectedness of human, animal, and environmental health. This approach underscores the importance of preserving biodiversity and ecosystem integrity as key components of disease prevention and control. As a result, the Global Wildlife Health Market encompasses not only biomedical interventions but also ecosystem management strategies, such as habitat restoration, wildlife conservation, and wildlife trade regulation.

The market is characterized by a diverse array of stakeholders, including government agencies, non-profit organizations, research institutions, pharmaceutical companies, and wildlife conservation groups, all of which play crucial roles in shaping policies, funding research, and implementing interventions. However, the market also faces challenges, including funding constraints, regulatory hurdles, and the inherent complexities of working with diverse wildlife species and ecosystems. Additionally, ethical considerations surrounding wildlife research and management, such as animal welfare and indigenous rights, pose important questions that require careful deliberation.

Key Market Drivers

Increasing Zoonotic Disease Threats

Increasing zoonotic disease threats are driving the growth of the Global Wildlife Health Market, as the interconnectedness of human, animal, and environmental health becomes more apparent. Zoonotic diseases, which originate in animals and can be transmitted to humans, pose significant public health risks and economic burdens. Events such as the Ebola outbreak in Africa, the SARS epidemic, and the ongoing COVID-19 pandemic have highlighted the urgency of understanding and managing diseases in wildlife populations to prevent spillover into humans.

As zoonotic diseases continue to emerge and spread, there is a growing recognition of the need for proactive measures to monitor and control wildlife health. This heightened awareness has spurred investment in wildlife health research, surveillance, and interventions aimed at reducing the risk of future pandemics. Governments, non-profit organizations, research institutions, and pharmaceutical companies are allocating resources towards developing innovative solutions for wildlife disease detection, diagnosis, and management.

Technological advancements play a crucial role in enhancing our ability to monitor wildlife health and detect emerging infectious diseases. Remote sensing technologies, such as satellite imagery and unmanned aerial vehicles (UAVs), enable researchers to track changes in habitat and behavior patterns that may indicate disease outbreaks. Molecular diagnostics and genomic sequencing have revolutionized our ability to identify pathogens and trace their transmission pathways, facilitating early detection and response efforts. Additionally, advances in vaccine development and delivery systems hold promise for protecting wildlife populations from infectious diseases.

The increasing threat of zoonotic diseases has also led to a shift in public attitudes towards wildlife conservation and ecosystem health. There is a growing recognition of the importance of preserving biodiversity and ecosystem integrity as essential components of disease prevention and control. This holistic perspective, known as the One Health approach, emphasizes the interconnectedness of human, animal, and environmental health and underscores the need for interdisciplinary collaboration to address complex health challenges.

Technological Advancements

Technological advancements are playing a pivotal role in boosting the Global Wildlife Health Market, revolutionizing the way researchers monitor, diagnose, and manage diseases in wild animal populations. These advancements are driving innovation in wildlife health research, surveillance, and interventions, ultimately contributing to the preservation of biodiversity and the protection of human and animal health. One of the most significant technological advancements in wildlife health is the development of remote sensing technologies. Satellite imagery and unmanned aerial vehicles (UAVs) allow researchers to monitor wildlife populations from a distance, providing valuable insights into habitat use, migration patterns, and population dynamics. These tools enable early detection of changes in wildlife health indicators, such as altered behavior or habitat degradation, which may signal the presence of infectious diseases.

In addition to remote sensing, molecular diagnostics and genomic sequencing have transformed our ability to identify pathogens and track disease transmission pathways in wildlife populations. Rapid advances in DNA sequencing technologies have made it possible to rapidly sequence the genomes of viruses, bacteria, and other pathogens, facilitating the development of targeted diagnostic tests and vaccines. These tools are essential for detecting emerging infectious diseases in wildlife and understanding their potential risks to human and animal health.

Advances in vaccine development and delivery systems hold promise for protecting wildlife populations from infectious diseases. Novel vaccine formulations, such as oral vaccines and DNA vaccines, offer new strategies for immunizing wild animal populations against infectious diseases. These vaccines can be distributed via bait stations or deployed using drone technology, enabling large-scale vaccination campaigns in remote or inaccessible areas.

Technological advancements are also driving innovation in wildlife health monitoring and surveillance. Integrated sensor networks, equipped with environmental sensors, GPS trackers, and health monitoring devices, provide real-time data on wildlife health and behavior. Machine learning algorithms and artificial intelligence systems analyze large datasets to identify patterns and detect anomalies, enabling early warning systems for disease outbreaks.

Growing One Health Approach

The growing adoption of the One Health approach is significantly boosting the Global Wildlife Health Market, as it emphasizes the interconnectedness of human, animal, and environmental health. This holistic perspective recognizes that the health of humans, animals, and ecosystems are intricately linked, and addresses health challenges through collaborative, interdisciplinary efforts.

One of the key drivers behind the increasing adoption of the One Health approach is the recognition of the role of wildlife in the emergence and spread of infectious diseases. Zoonotic diseases, which originate in animals and can be transmitted to humans, pose significant public health risks. Events such as the Ebola outbreak in Africa, the SARS epidemic, and the ongoing COVID-19 pandemic have underscored the importance of understanding and managing diseases in wildlife populations to prevent spillover into humans.

The One Health approach emphasizes the importance of preserving biodiversity and ecosystem integrity as essential components of disease prevention and control. Healthy ecosystems provide essential services, such as regulating infectious disease transmission, maintaining clean air and water, and supporting food security and livelihoods. By addressing the underlying drivers of ecosystem degradation and biodiversity loss, such as habitat destruction, climate change, and wildlife trade, the One Health approach aims to reduce the risk of disease emergence and transmission.

The One Health approach encourages collaboration between human health, animal health, and environmental sectors to address complex health challenges. Governments, non-profit organizations, research institutions, and industry stakeholders are increasingly working together to develop integrated solutions for wildlife health management and conservation. This collaborative approach enables the sharing of knowledge, resources, and expertise across disciplines, leading to more effective disease surveillance, diagnosis, and control efforts.

Key Market Challenges

Funding Constraints

One of the primary challenges hindering the Global Wildlife Health Market is funding constraints. Wildlife health research and interventions require significant financial resources, including funding for research projects, fieldwork, equipment, and personnel. However, funding for wildlife health initiatives is often limited, with competing priorities for public and private sector funding. As a result, many wildlife health programs face budgetary constraints, limiting their capacity to conduct research, monitor wildlife populations, and implement disease control measures effectively.

Regulatory Hurdles

Regulatory hurdles pose significant challenges to the development and implementation of wildlife health interventions. Wildlife health research often involves working with protected species and sensitive ecosystems, requiring compliance with a complex array of regulations and permitting requirements. Obtaining permits for research activities can be time-consuming and costly, leading to delays in project implementation. Additionally, regulatory frameworks for wildlife health may vary between countries and regions, creating inconsistencies and barriers to collaboration across borders.

Data Limitations

Data limitations present challenges to wildlife health research and surveillance efforts. Gathering data on wildlife populations, including population sizes, distribution patterns, and health status, can be logistically challenging, particularly for species that are elusive or occur in remote or inaccessible areas. Additionally, data on wildlife diseases may be limited, particularly for emerging or understudied pathogens. As a result, there may be gaps in our understanding of disease dynamics in wildlife populations, hindering efforts to assess and mitigate health risks.

Key Market Trends

Rising Awareness of Zoonotic Disease Threats

The rising awareness of zoonotic disease threats is significantly boosting the Global Wildlife Health Market, prompting increased investment in wildlife health research, surveillance, and interventions. Zoonotic diseases, which originate in animals and can be transmitted to humans, pose significant public health risks and economic burdens. Events such as the Ebola outbreak in Africa, the SARS epidemic, and the ongoing COVID-19 pandemic have underscored the urgency of understanding and managing diseases in wildlife populations to prevent spillover into humans.

As zoonotic diseases continue to emerge and spread, there is growing recognition of the need for proactive measures to monitor and control wildlife health. This heightened awareness has spurred investment from governments, non-profit organizations, research institutions, and pharmaceutical companies towards developing innovative solutions for wildlife disease detection, diagnosis, and management.

The recognition of zoonotic disease threats has led to a paradigm shift towards a One Health approach, which emphasizes the interconnectedness of human, animal, and environmental health. This holistic perspective underscores the importance of preserving biodiversity and ecosystem integrity as essential components of disease prevention and control. As a result, there is growing investment in wildlife conservation efforts, habitat restoration, and sustainable wildlife management practices, all of which contribute to the health and well-being of both wildlife and human populations.

Technological advancements play a crucial role in enhancing our ability to monitor wildlife health and detect emerging infectious diseases. Remote sensing technologies, such as satellite imagery and unmanned aerial vehicles (UAVs), enable researchers to track changes in habitat and behavior patterns that may indicate disease outbreaks. Molecular diagnostics and genomic sequencing have revolutionized our ability to identify pathogens and trace their transmission pathways, facilitating early detection and response efforts. Additionally, advances in vaccine development and delivery systems hold promise for protecting wildlife populations from infectious diseases.

Increasing Public and Private Investments

Increasing public and private investments are playing a crucial role in boosting the Global Wildlife Health Market, driving advancements in research, surveillance, and interventions aimed at protecting wildlife populations and mitigating the risks of zoonotic disease transmission. Governments, non-profit organizations, research institutions, and pharmaceutical companies are allocating resources towards wildlife health research, surveillance, and conservation initiatives. Public sector investments support projects aimed at preventing, detecting, and responding to emerging infectious diseases in wildlife and humans. For example, initiatives such as the United States Agency for International Development's (USAID) Emerging Pandemic Threats Program and the World Health Organization's (WHO) Global Outbreak Alert and Response Network (GOARN) provide financial support for wildlife health research and capacity-building efforts in regions vulnerable to zoonotic disease outbreaks.

Private sector investment in wildlife health research and product development is driving innovation and facilitating the commercialization of wildlife health products and services. Pharmaceutical companies are investing in the development of vaccines and therapeutics tailored to wildlife species, as well as diagnostic tools and surveillance technologies for monitoring wildlife health. Additionally, companies involved in wildlife conservation and ecotourism are investing in initiatives aimed at protecting wildlife habitats and promoting sustainable wildlife management practices.

The increasing public and private investments in the Global Wildlife Health Market are fueled by growing recognition of the economic, ecological, and public health impacts of wildlife diseases. Zoonotic diseases, which can jump from animals to humans, pose significant risks to human health, livelihoods, and economies. Events such as the Ebola outbreak in Africa, the SARS epidemic, and the ongoing COVID-19 pandemic have underscored the importance of understanding and managing diseases in wildlife populations to prevent spillover into humans.

Investments in wildlife health research and interventions are driven by a desire to preserve biodiversity and ecosystem integrity. Healthy ecosystems provide essential services, such as regulating infectious disease transmission, maintaining clean air and water, and supporting food security and livelihoods. By investing in wildlife health, stakeholders are contributing to the preservation of biodiversity and the protection of human and animal health for future generations.

Segmental Insights

Animal Type Insights

Based on the animal type, mammals segment emerged as the dominant segment in the global wildlife health market in 2023. Mammals serve as reservoirs for many zoonotic diseases, posing significant risks to human health. Diseases such as rabies, Ebola, and COVID-19 have all been transmitted from mammals to humans, underscoring the importance of monitoring and managing health issues in mammalian populations. Additionally, mammals play crucial roles in ecosystem dynamics and functioning. As keystone species, mammals influence the structure and function of ecosystems through their interactions with other species and their roles as predators, prey, and seed dispersers.

Product Insights

Based on the product, medicine segment emerged as the dominant segment in the global wildlife health market in 2023. This dominance can be attributed to the increasing demand for pharmaceutical interventions aimed at addressing wildlife health issues. The rise in zoonotic disease threats, habitat degradation, and climate change-related stressors has led to an urgent need for medicines to treat and prevent diseases in wildlife populations. Pharmaceutical companies are investing in the development of vaccines, antibiotics, antiparasitic drugs, and other therapeutics tailored to wildlife species.

Regional Insights

North America emerged as the dominant region in the Global Wildlife Health Market in 2023, holding the largest market share. North America boasts advanced healthcare infrastructure and a robust research ecosystem, comprising leading universities, research institutions, and pharmaceutical companies dedicated to wildlife health. This research infrastructure enables the development of cutting-edge technologies, diagnostic tools, and pharmaceutical interventions tailored to address wildlife health issues effectively.

Key Market Players

Boehringer Ingelheim International GmbH

NexGen Pharmaceuticals LLC

Virbac S.A.

Dong Bang Co., Ltd.

Pneu-Dart Inc.

DANiNJECT

Genia Inc.

Wedgewood Pharmacy LLC

The Pet Apothecary

Taylors Pharmacy LLC

Report Scope:

In this report, the Global Wildlife Health Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Wildlife Health Market, By Animal Type:

Mammals Birds Fish Reptiles Amphibians

Wildlife Health Market, By Product:

Medicine Equipment & Consumables

Wildlife Health Market, By Route of Administration:

Oral Injectables Others

Wildlife Health Market, By End Use:

Zoos Wildlife Sanctuaries Wildlife Rescue & Rehab Centers Others

Wildlife Health Market, By Region:

North America

United States

Canada

Mexico

Europe

France

United Kingdom

Italy

Germany

Spain

Asia-Pacific

China

India

Japan

Australia

South Korea

South America

Brazil

Argentina

Colombia

Middle East & Africa

South Africa

Saudi Arabia

UAE

Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Wildlife Health Market.

Available Customizations:

Global Wildlife Health Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Wildlife Health Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Animal Type (Mammals, Birds, Fish, Reptiles, Amphibians)
  • 5.2.2. By Product (Medicine, Equipment & Consumables)
  • 5.2.3. By Route of Administration (Oral, Injectables, Others)
  • 5.2.4. By End-Use (Zoos, Wildlife Sanctuaries, Wildlife Rescue & Rehab Centers, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2023)
• 5.3. Market Map
  • 5.3.1. By Animal Type
  • 5.3.2. By Product
  • 5.3.3. By Route of Administration
  • 5.3.4. By End Use
  • 5.3.5. By Region

6. Asia Pacific Wildlife Health Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Animal Type
  • 6.2.2. By Product
  • 6.2.3. By Route of Administration
  • 6.2.4. By End-Use
  • 6.2.5. By Country
• 6.3. Asia Pacific: Country Analysis
  • 6.3.1. China Wildlife Health Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Animal Type
      • 6.3.1.2.2. By Product
      • 6.3.1.2.3. By Route of Administration
      • 6.3.1.2.4. By End-Use
  • 6.3.2. India Wildlife Health Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Animal Type
      • 6.3.2.2.2. By Product
      • 6.3.2.2.3. By Route of Administration
      • 6.3.2.2.4. By End-Use
  • 6.3.3. Australia Wildlife Health Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Animal Type
      • 6.3.3.2.2. By Product
      • 6.3.3.2.3. By Route of Administration
      • 6.3.3.2.4. By End-Use
  • 6.3.4. Japan Wildlife Health Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Animal Type
      • 6.3.4.2.2. By Product
      • 6.3.4.2.3. By Route of Administration
      • 6.3.4.2.4. By End-Use
  • 6.3.5. South Korea Wildlife Health Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Animal Type
      • 6.3.5.2.2. By Product
      • 6.3.5.2.3. By Route of Administration
      • 6.3.5.2.4. By End-Use

7. Europe Wildlife Health Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Animal Type
  • 7.2.2. By Product
  • 7.2.3. By Route of Administration
  • 7.2.4. By End-Use
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Wildlife Health Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Animal Type
      • 7.3.1.2.2. By Product
      • 7.3.1.2.3. By Route of Administration
      • 7.3.1.2.4. By End-Use
  • 7.3.2. Germany Wildlife Health Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Animal Type
      • 7.3.2.2.2. By Product
      • 7.3.2.2.3. By Route of Administration
      • 7.3.2.2.4. By End-Use
  • 7.3.3. Spain Wildlife Health Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Animal Type
      • 7.3.3.2.2. By Product
      • 7.3.3.2.3. By Route of Administration
      • 7.3.3.2.4. By End-Use
  • 7.3.4. Italy Wildlife Health Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Animal Type
      • 7.3.4.2.2. By Product
      • 7.3.4.2.3. By Route of Administration
      • 7.3.4.2.4. By End-Use
  • 7.3.5. United Kingdom Wildlife Health Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Animal Type
      • 7.3.5.2.2. By Product
      • 7.3.5.2.3. By Route of Administration
      • 7.3.5.2.4. By End-Use

8. North America Wildlife Health Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Animal Type
  • 8.2.2. By Product
  • 8.2.3. By Route of Administration
  • 8.2.4. By End-Use
  • 8.2.5. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Wildlife Health Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Animal Type
      • 8.3.1.2.2. By Product
      • 8.3.1.2.3. By Route of Administration
      • 8.3.1.2.4. By End-Use
  • 8.3.2. Mexico Wildlife Health Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Animal Type
      • 8.3.2.2.2. By Product
      • 8.3.2.2.3. By Route of Administration
      • 8.3.2.2.4. By End-Use
  • 8.3.3. Canada Wildlife Health Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Animal Type
      • 8.3.3.2.2. By Product
      • 8.3.3.2.3. By Route of Administration
      • 8.3.3.2.4. By End-Use

9. South America Wildlife Health Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Animal Type
  • 9.2.2. By Product
  • 9.2.3. By Route of Administration
  • 9.2.4. By End-Use
  • 9.2.5. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Wildlife Health Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Animal Type
      • 9.3.1.2.2. By Product
      • 9.3.1.2.3. By Route of Administration
      • 9.3.1.2.4. By End-Use
  • 9.3.2. Argentina Wildlife Health Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Animal Type
      • 9.3.2.2.2. By Product
      • 9.3.2.2.3. By Route of Administration
      • 9.3.2.2.4. By End-Use
  • 9.3.3. Colombia Wildlife Health Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Animal Type
      • 9.3.3.2.2. By Product
      • 9.3.3.2.3. By Route of Administration
      • 9.3.3.2.4. By End-Use

10. Middle East and Africa Wildlife Health Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Animal Type
  • 10.2.2. By Product
  • 10.2.3. By Route of Administration
  • 10.2.4. By End-Use
  • 10.2.5. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Wildlife Health Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Animal Type
      • 10.3.1.2.2. By Product
      • 10.3.1.2.3. By Route of Administration
      • 10.3.1.2.4. By End-Use
  • 10.3.2. Saudi Arabia Wildlife Health Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Animal Type
      • 10.3.2.2.2. By Product
      • 10.3.2.2.3. By Route of Administration
      • 10.3.2.2.4. By End-Use
  • 10.3.3. UAE Wildlife Health Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Animal Type
      • 10.3.3.2.2. By Product
      • 10.3.3.2.3. By Route of Administration
      • 10.3.3.2.4. By End-Use
  • 10.3.4. Egypt Wildlife Health Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Animal Type
      • 10.3.4.2.2. By Product
      • 10.3.4.2.3. By Route of Administration
      • 10.3.4.2.4. By End-Use

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches (If Any)
• 12.3. Mergers & Acquisitions (If Any)

13. Global Wildlife Health Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Product

15. Competitive Landscape

• 15.1. Boehringer Ingelheim International GmbH
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. NexGen Pharmaceuticals LLC
• 15.3. Virbac S.A.
• 15.4. Dong Bang Co., Ltd.
• 15.5. Pneu-Dart Inc.
• 15.6. DANiNJECT
• 15.7. Genia Inc.
• 15.8. Wedgewood Pharmacy LLC
• 15.9. The Pet Apothecary
• 15.10. Taylors Pharmacy LLC

16. Strategic Recommendations

17. About Us & Disclaimer